Screener
Eligibility screening
Long-term Safety and Efficacy Evaluation of Lunsekimig (SAR443765) in Adult Participants With Asthma
24 US sites in AZ, CO, FL, MI +6
Before we begin
Who are you filling this out for?
Your answer affects how the questions are phrased.